StateHouse Holdings Inc.
StateHouse Holdings Inc.
Your view on STHZF
Overview
What the company does, where it operates, and who runs it.
About StateHouse Holdings Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Edward Schmults
- Headquarters
- 1295 West Morena Blvd, San Diego, CA, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Edward Schmults
- Headquarters
- 1295 West Morena Blvd, San Diego, CA, US
StateHouse Holdings Inc. is involved in the cultivation, processing, manufacture, distribution, and retailing of cannabis products for the adult-use and medical markets in the United States. It operates 13 retail dispensaries in California and one in Oregon; and a retail dispensary in the Haight Ashbury area of San Francisco, California.
The company was formerly known as Harborside Inc. and changed its name to StateHouse Holdings Inc. in July 2022. StateHouse Holdings Inc. is headquartered in San Diego, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for StateHouse Holdings Inc., and the rating behind it. STHZF last traded at $0.0010; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for StateHouse Holdings Inc.. Starting points for StateHouse Holdings Inc.: EPS -$0.20, beta 1.79 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for StateHouse Holdings Inc.. StateHouse Holdings Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for StateHouse Holdings Inc.. Trailing twelve-month EPS for StateHouse Holdings Inc. stands at -$0.20. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for StateHouse Holdings Inc.. StateHouse Holdings Inc. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
StateHouse Holdings Inc. valued side by side against its closest peers. StateHouse Holdings Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold StateHouse Holdings Inc., and how their positions are changing. At a $356,014 market value, institutional positions materially move StateHouse Holdings Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by StateHouse Holdings Inc. executives and directors. Shares of StateHouse Holdings Inc. have traded between $0.0001 and $0.01 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming StateHouse Holdings Inc.. StateHouse Holdings Inc. is a $356,014 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming StateHouse Holdings Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for StateHouse Holdings Inc.. Coverage tracks StateHouse Holdings Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.